Pharma BD Deal Intelligence
3M's $1.0 billion buy of M*Modal's AI clinical documentation business closed cleanly in Q2 2019, but the asset didn't stay put: on April 1, 2024, 3M spun its health care unit off as Solventum Corporation, taking M*Modal's tech along with it.
Outcome grade pending — assessed 5 years post-close.
Full analysis, sources & comparables →This acquisition builds on our strategic commitment to invest in our Health Information Systems business and expands the capabilities of our revenue cycle…
M*Modal generates roughly $200 million in annual revenue and brings ~750 employees. Notable history: filed Chapter 11 in 2014 after 2012 acquisition by One…
3M completed the $1B acquisition of M*Modal's technology business, framed as a strategic expansion of revenue cycle management and population health. Excluded:…
Source summaries from our enrichment pipeline; follow links for originals.
All 7 sources with sentiment breakdown →
3M agreed to acquire M*Modal's technology business for $1.0 billion in enterprise value to strengthen 3M Health Information Systems with AI-powered clinical documentation. Closed in Q2 2019.
Assessment window: 5yr post-close.
$1.3B US clinical documentation improvement market 2024 (10.7% CAGR 2019-2023) · ~$200M M*Modal annual revenue at deal time
Clinical documentation improvement (CDI) addresses physician burnout and revenue-cycle accuracy by capturing patient encounters into structured EHR data. Manual documentation consumes hours of physician time daily, driving demand for AI-powered conversational platforms that draft notes, surface coding gaps, and translate dictation into billable, queryable records.
The 2018-2019 CDI/clinical AI market was a contested arena. Nuance Communications (Dragon Medical, later acquired by Microsoft for $19.7B in 2021) was the runaway leader in physician dictation, deeply embedded with Epic. Cerner had partnered with 3M on population health (2016) and with Nuance for ambient voice. Alphabet's Verily collaborated with Stanford on AI scribes, and startups Suki and Saykara were attacking the ambient-AI workflow. By acquiring M*Modal's tech business (~$200M revenue, 750 employees) for $1B enterprise value, 3M consolidated cloud conversational AI inside its existing 3M Health Information Systems franchise, the dominant vendor in computer-assisted coding (CAC) and ICD-10 grouping. The deal positioned 3M HIS to bundle AI-powered CDI with revenue cycle management against Nuance/Epic and to defend its coding moat as ambient AI commoditized dictation. Excluded from the deal: M*Modal's transcription/scribing services, which remained a separately operated business strategically aligned with 3M.
| Deal | Year | Value | Outcome |
|---|---|---|---|
| 3M Company / M*Modal (this deal) | 2019 | $1.0B | — |
| Watson Pharmaceuticals (Actavis Inc.) / Actavis plc | 2012 | $5.9B | 97 |
| Kohlberg Kravis Roberts & Co. / PRA International (Genstar Capital) | 2013 | $1.3B | 91 |
| Stryker Corporation / MAKO Surgical Corp. | 2013 | $1.6B | 91 |
| Quintiles Transnational Holdings Inc. / IMS Health Holdings, Inc. | 2016 | $17.6B | 91 |
| DPx Holdings B.V. (JLL Partners 51% / Royal DSM 49%) / Patheon Inc. + DSM Pharmaceutical Products | 2013 | $2.6B | 90 |
| Pamplona Capital Management, LLP / PAREXEL International Corporation | 2017 | $5.0B | 90 |
← Browse all deals · How we score deals
More: 2019 deals · Other deals